Pharmaceuticals and the Developing World
Pharmaceuticals have greatly improved health in developing countries, but many people in developing countries do not obtain even inexpensive pharmaceuticals and little pharmaceutical R&D is oriented toward products needed by developing countries, such as a malaria vaccine. Access to existing products could be improved by facilitating differential pricing, for example by subsidizing donation programs, and reforming health care delivery. R&D incentives could be improved if rich countries or international organization committed to purchase needed products when they are developed and make them available to the poor.
Year of publication: |
2002
|
---|---|
Authors: | Kremer, Michael |
Published in: |
Journal of Economic Perspectives. - American Economic Association - AEA. - Vol. 16.2002, 4, p. 67-90
|
Publisher: |
American Economic Association - AEA |
Saved in:
Online Resource
Saved in favorites
Similar items by person
-
Vouchers for Private Schooling in Colombia: Evidence from a Randomized Natural Experiment
Angrist, Joshua, (2002)
-
Kremer, Michael, (2003)
-
Angrist, Joshua, (2004)
- More ...